Patents by Inventor Alan DeAngelis

Alan DeAngelis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11374180
    Abstract: Compounds are provided that comprise a ligand having a 5-substituted 2-phenylquinoline. In particular, the 2-phenylquinoline may be substituted with a cycloalkyl containing group at the 5-position. These compounds may be used in organic light emitting devices, in particular as red emitters in the emissive layer of such devices, to provide devices having improved properties.
    Type: Grant
    Filed: April 29, 2020
    Date of Patent: June 28, 2022
    Assignee: UNIVERSAL DISPLAY CORPORATION
    Inventors: Chuanjun Xia, Bin Ma, David Zenan Li, Bert Alleyne, Alan Deangelis, James Fiordeliso, Vadim Adamovich
  • Patent number: 11296283
    Abstract: A compound including a ligand LA of Formula I is disclosed.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: April 5, 2022
    Assignee: UNIVERSAL DISPLAY CORPORATION
    Inventors: Zhiqiang Ji, Pierre-Luc T. Boudreault, Alexey Borisovich Dyatkin, Jui-Yi Tsai, Jerald Feldman, Bin Ma, Alan Deangelis
  • Publication number: 20220077408
    Abstract: Provided are organometallic compounds having a ligand LA of Formula I: Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.
    Type: Application
    Filed: August 18, 2021
    Publication date: March 10, 2022
    Applicant: Universal Display Corporation
    Inventors: Zhiqiang JI, Wei-Chun Shih, Alan DeAngelis, Pierre-Luc T. Boudreault
  • Publication number: 20220037598
    Abstract: A compound comprising a heteroleptic iridium complex having a structure of Formula II, is provided. In Formula II, each of R1, R2, R3, R4, R5, and R6, is independently selected from the group consisting of hydrogen, deuterium, cycloalkyl, deuterated cycloalkyl, alkyl, and deuterated alkyl; at least one of R1, R2, R3, R4, R5, and R6 is not hydrogen or deuterium; and each R and R? is independently selected from a variety of substitutions. OLEDs and formulations containing the compound of Formula II are also provided.
    Type: Application
    Filed: October 6, 2021
    Publication date: February 3, 2022
    Applicant: Universal Display Corporation
    Inventors: BIN MA, Alan Deangelis, Chuanjun Xia, Bert Alleyne
  • Publication number: 20220009955
    Abstract: A compound comprising a first bidentate ligand LA, wherein LA comprises a structure of Formula I; wherein Z is selected from the group consisting of O, S, NR, BR, CRKRL, C?CRKRL, SiRKRL, —CRKRLCRMRN—, —SiRKRLSiRMRN—, —CRKRLO—, —SiRKRLO—, and —CRK?CRL—; wherein ring A, ring B, and ring C are each independently a 5-membered carbocyclic ring, 5-membered heterocyclic ring, 6-membered carbocyclic ring or 6-membered heterocyclic ring; wherein LA is coordinated to a metal M forming a 5-membered chelate ring; wherein M is selected from the group consisting of Ir, Pt, Pd, Ru, Rh, Os, Re, Cu, Ag, and Au; wherein RA, RB, and RC each represent mono to the maximum allowable substitution, or no substitution; wherein each R, RK, RL, RM, RN, RA, RB, and RC is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, selenyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, a
    Type: Application
    Filed: September 14, 2021
    Publication date: January 13, 2022
    Inventors: Alexey Borisovich Dyatkin, Jui-Yi Tsai, Walter Yeager, Pierre-Luc T. Boudreault, Zhiqiang Ji, Alan DeAngelis
  • Patent number: 11189805
    Abstract: Heteroleptic iridium complexes having the formula are disclosed. In this formula, R1, R2, R3, R4, R5, and R6, are selected from hydrogen, deuterium, cycloalkyl, deuterated cycloalkyl, alkyl, and deuterated alkyl, and can optionally be linked together to form a ring; at least one of R1, R2, R3, R4, R5, and R6 is cycloalkyl, deuterated cycloalkyl, alkyl, or deuterated alkyl; ring A is attached to the 4- or 5-position of ring B; and R and R? can represent any of a variety of subsitutents. These iridium compounds contain alkyl substituted phenylpyridine ligands, which provide these compounds with beneficial properties when the iridium complexes are incorporated into OLED devices.
    Type: Grant
    Filed: October 24, 2018
    Date of Patent: November 30, 2021
    Assignee: UNIVERSAL DISPLAY CORPORATION
    Inventors: Bin Ma, Alan DeAngelis, Chuanjun Xia, Bert Alleyne
  • Publication number: 20210323968
    Abstract: A compound containing indolocarbazole having a formula: Formula I is disclosed.
    Type: Application
    Filed: June 15, 2021
    Publication date: October 21, 2021
    Applicant: UNIVERSAL DISPLAY CORPORATION
    Inventors: BIN MA, VADIM ADAMOVICH, ALAN DEANGELIS, TING-CHIH WANG
  • Patent number: 11117897
    Abstract: A compound containing indolocarbazole having a formula: Formula I is disclosed.
    Type: Grant
    Filed: March 22, 2018
    Date of Patent: September 14, 2021
    Assignee: UNIVERSAL DISPLAY CORPORATION
    Inventors: Bin Ma, Vadim Adamovich, Alan Deangelis, Ting-Chih Wang
  • Patent number: 11114624
    Abstract: The present invention includes a new series of benzofused heterocyclic ligands for metal complexes. These complexes show promising photophysical performance when incorporated into OLEDs.
    Type: Grant
    Filed: March 17, 2020
    Date of Patent: September 7, 2021
    Assignee: UNIVERSAL DISPLAY CORPORATION
    Inventors: Mingjuan Su, Walter Yeager, Alan Deangelis, Bin Ma, Jui-Yi Tsai, Lichang Zeng, Chuanjun Xia
  • Patent number: 11108000
    Abstract: A compound having the formula Ir(LA)n(LB)3?n is disclosed wherein LA is an aza-DBF ligand and LB is an alkyl-substituted phenylpyridine ligand, wherein the compound has a structure according to Formula I: wherein A1, A2, A3, A4, A5, A6, A7, and A8 comprise carbon or nitrogen; wherein at least one of A1, A2, A3, A4, A5, A6, A7, and A8 is nitrogen; wherein ring B is bonded to ring A through a C—C bond; wherein the iridium is bonded to ring A through a Ir—C bond; wherein X is O, S, or Se; wherein R1 and R2 each independently represent mono-, di-, tri-, tetra-substitution, or no substitution; wherein R? and R? each independently represent mono-, di-substitution, or no substitution; wherein any adjacent substitutions in R?, R?, R1, R2, R3, R4, R5, and R6 are optionally linked together to form a ring; wherein R1, R2, R?, and R? are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl,
    Type: Grant
    Filed: May 3, 2018
    Date of Patent: August 31, 2021
    Assignee: UNNIVERSAL DISPLAY CORPORATION
    Inventors: Bin Ma, Walter Yeager, Edward Barron, Alan Deangelis, Chuanjun Xia, Vadim Adamovich, Scott Beers, Harvey R. Wendt, Suman Layek
  • Patent number: 10978648
    Abstract: Novel heteroleptic iridium carbene complexes are provided. The complexes have lower-than expected sublimation temperatures, which is beneficial for the processing of these materials in solid state applications. Selective substitution of the ligands provides for phosphorescent compounds that are suitable for use in a variety of OLED devices. The carbene complexes can also be used as materials in a hole blocking layer and/or an electron transport layer to improve device performance.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: April 13, 2021
    Assignee: UNIVERSAL DISPLAY CORPORATION
    Inventors: Chun Lin, Bin Ma, Chuanjun Xia, Lichang Zeng, Alan Deangelis, Edward Barron
  • Publication number: 20210095195
    Abstract: A compound having a Pt tetradentate structure of Formula 1, is provided. In the structure of Formula 1, rings C and D each independently represent 5- or 6-membered carbocyclic or heterocyclic ring; L1, L2, and L3 are each independently a direct bond, BR, NR, PR, O, S, Se, C?O, S?O, SO2, SiRR?, GeRR?, alkyl, cycloalkyl, or a combination thereof; the sum of n1 and n2 is 1 or 2; X is selected from NRE, O, S, and Se; X3 and X4 each independently carbon or nitrogen; and one of Q1, Q3, and Q4 is oxygen, and the remaining two of Q1, Q3, and Q4 each represents a direct bond. Formulations and devices, such as an OLEDs, that include the compound of Formula 1 are also described.
    Type: Application
    Filed: December 10, 2020
    Publication date: April 1, 2021
    Applicant: Universal Display Corporation
    Inventors: Bin MA, Mingjuan SU, Alan DEANGELIS, Edward BARRON, Chuanjun XIA
  • Publication number: 20210083202
    Abstract: A compound useful as a host material in an OLED is provided. The compound includes at least one chemical group selected from the group consisting of triphenylene, carbazole, indolocarbazole, dibenzothiphene, dibenzofuran, dibenzoselenophene, aza-triphenylene, azacarbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene; wherein the compound is substituted by at least one R selected from the group consisting of alkyl, cycloalkyl, spiroalkyl, partially or fully deuterated variants thereof, partially or fully fluorinated variants thereof, and combination thereof.
    Type: Application
    Filed: November 24, 2020
    Publication date: March 18, 2021
    Applicant: Universal Display Corporation
    Inventors: BIN MA, ALAN DEANGELIS
  • Publication number: 20210074931
    Abstract: A compound of: is disclosed. In Formula IV, ring B and ring C are each independently a 5 or 6-membered carbocyclic or heterocyclic ring; A-B represents a bonded pair of carbocyclic or heterocyclic rings coordinated to a metal M via a nitrogen atom in ring A and an sp2 hybridized atom in ring B; A-C represents a bonded pair of carbocyclic or heterocyclic rings; M is a metal having an atomic number greater than 40; L? is a monoanionic bidentate ligand; m is the oxidation state of the metal M; and n is at least 1.
    Type: Application
    Filed: November 19, 2020
    Publication date: March 11, 2021
    Applicant: Universal Display Corporation
    Inventors: Chuanjun XIA, Bert ALLEYNE, Raymond C. KWONG, James FIORDELISO, Michael S. WEAVER, Nasrin ANSARI, Alan DEANGELIS, Dinesh RAYABARAPU, Vadim ADAMOVICH
  • Patent number: 10897016
    Abstract: A compound useful as a host material in an OLED is provided. The compound includes at least one chemical group selected from the group consisting of triphenylene, carbazole, indolocarbazole, dibenzothiphene, dibenzofuran, dibenzoselenophene, aza-triphenylene, azacarbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene; wherein the compound is substituted by at least one R selected from the group consisting of alkyl, cycloalkyl, spiroalkyl, partially or fully deuterated variants thereof, partially or fully fluorinated variants thereof, and combination thereof.
    Type: Grant
    Filed: October 20, 2017
    Date of Patent: January 19, 2021
    Assignee: UNIVERSAL DISPLAY CORPORATION
    Inventors: Bin Ma, Alan Deangelis
  • Patent number: 10892426
    Abstract: An OLED containing an emissive dopant that is a heteroleptic complex having the formula Ir(LA-B)2(LC-D) is disclosed.
    Type: Grant
    Filed: January 14, 2020
    Date of Patent: January 12, 2021
    Assignee: UNIVERSAL DISPLAY CORPORATION
    Inventors: Chuanjun Xia, Bert Alleyne, Raymond C. Kwong, James Fiordeliso, Michael S. Weaver, Nasrin Ansari, Alan Deangelis, Dinesh Rayabarapu, Vadim Adamovich
  • Patent number: 10889754
    Abstract: A compound having a Pt tetradentate structure of Formula 1, is provided. In the structure of Formula 1, rings C and D each independently represent 5- or 6-membered carbocyclic or heterocyclic ring; L1, L2, and L3 are each independently a direct bond, BR, NR, PR, O, S, Se, C?O, S?O, SO2, SiRR?, GeRR?, alkyl, cycloalkyl, or a combination thereof; the sum of n1 and n2 is 1 or 2; X is selected from NRE, O, S, and Se; X3 and X4 each independently carbon or nitrogen; and one of Q1, Q3, and Q4 is oxygen, and the remaining two of Q1, Q3, and Q4 each represents a direct bond. Formulations and devices, such as an OLEDs, that include the compound of Formula 1 are also described.
    Type: Grant
    Filed: October 18, 2018
    Date of Patent: January 12, 2021
    Assignee: UNIVERSAL DISPLAY CORPORATION
    Inventors: Bin Ma, Mingjuan Su, Alan Deangelis, Edward Barron, Chuanjun Xia
  • Publication number: 20210002311
    Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.
    Type: Application
    Filed: June 12, 2020
    Publication date: January 7, 2021
    Applicant: Universal Display Corporation
    Inventors: Zhiqiang JI, Pierre-Luc T. BOUDREAULT, Wei-Chun SHIH, Alan DEANGELIS
  • Patent number: 10840458
    Abstract: Novel organic materials containing indolocarbazoles as donor connected with electron acceptors such as quinoxaline or dibenzoquinoxaline for PHOLED devices are disclosed.
    Type: Grant
    Filed: May 15, 2017
    Date of Patent: November 17, 2020
    Assignee: UNIVERSAL DISPLAY CORPORATION
    Inventors: Bin Ma, Alan Deangelis, Lichang Zeng, Chuanjun Xia, Jerald Feldman
  • Publication number: 20200308204
    Abstract: A compound comprising a first bidentate ligand LA, wherein LA comprises a structure of Formula I; wherein Z is selected from the group consisting of O, S, NR, BR, CRKRL, SiRKRL, —CRKRLCRMRN—, —SiRKRLSiRMRN—, —CRKRLO—, —SiRKRLO—, and —CRK?CRL—; wherein ring A, ring B, and ring C are each independently a 5-membered carbocyclic ring, 5-membered heterocyclic ring, 6-membered carbocyclic ring or 6-membered heterocyclic ring; wherein LA is coordinated to a metal M forming a 5-membered chelate ring; wherein M is selected from the group consisting of Ir, Pt, Pd, Ru, Rh, Os, Re, Cu, Ag, and Au; wherein RA, RB, and RC each represent mono to the maximum allowable substitution, or no substitution; wherein each R, RK, RL, RM, RN, RA, RB, and RC is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, car
    Type: Application
    Filed: March 26, 2020
    Publication date: October 1, 2020
    Inventors: Alexey Borisovich DYATKIN, Jui-Yi TSAI, Walter YEAGER, Pierre-Luc T. BOUDREAULT, Zhiqiang JI, Alan DeAngelis